Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses

Current atherosclerosis reports

Volumn 3, Issue 2, 2001, Pages 156-162

  Moriarty, Patrick M ^a   Gibson, Cheryl A ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN;

APHERESIS; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIABETIC NEPHROPATHY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; MALE; METHODOLOGY; PARTICLE SIZE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPSIS; SUDDEN DEAFNESS; TREATMENT OUTCOME;

BLOOD COMPONENT REMOVAL; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; DIABETIC NEPHROPATHIES; FEMALE; GRAFT REJECTION; HEARING LOSS, SUDDEN; HEART TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALE; PARTICLE SIZE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPSIS; TREATMENT OUTCOME;

EID: 0035286180     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-001-0052-5     Document Type: Review

References (0)